Evaluation of apamin effects on myelination process in C57BL/6 mice model of multiple sclerosis

Abstract

Multiple sclerosis (MS) is a demyelinating disease that causes chronic inflammation in the central nervous system. The aim of this study was to investigate the effects of apamin administration on myelination process. MS was induced by feeding cuprizone pellets (0.2%) for 6 weeks (demyelination phase) followed by normal feeding for additional 2 weeks (remyelination phase). Briefly, C57BL/6 male mice were randomly divided into six groups. Group 1, received the regular food pellets. Group 2 contained two subgroups of 6 animals each (n = 2 × 6). First group received cuprizone for 6 weeks and the sacrificed while the second group after 6 weeks of cuprizone, received no treatment for additional 2 weeks. Group 3 (co-treatment group) was composed of two subgroups of 6 animals each (n = 2 × 6). Both subgroups received apamin (100 μg/kg) intraperitoneally twice a week for 6 weeks. First subgroup terminated at this time and the second subgroup was fed normal diet for two additional weeks. Group 4 (post-treatment, n = 6) received apamin (100 μg/kg) intraperitoneally twice a week for 2 weeks after cuprizone secession. Groups 5 and 6 (vehicle, n = 6 in each group) received phosphate buffered saline as the vehicle of apamin during demyelination and remyelination phase. At the end of each phase, mice were deeply anesthetized and perfused. Groups 5 and 6 (vehicle) received PBS as the vehicle during both phases. Mice were anesthetized, perfused with PBS through their heart, and their brains were removed. Brain sections stained with luxol fast blue and the images were analyzed. Apamin co-treatment significantly increased the myelin content as compared to the cuprizone group. Also, mild elevation in the myelinated areas was observed with apamin post-treatment in comparison with remyelination phase. Our results revealed that apamin prevents myelin destruction more significantly as compared to remyelination process. This observation explains the possible role of apamin in inhibiting the activation of the microglia cells than stimulation of the oligodendrocytic precursor cells.

Evaluation of neuroprotective effects of alpha-tocopherol in cuprizone-induced demyelination model of multiple sclerosis

“…The copper chelator function of CPZ inhibited mitochondrial enzymes, leading to apoptosis of oligodendrocytes and subsequent demyelination ( 27 28 ). A previous study observed that the death of oligodendrocytes started at the end of the first week of CPZ exposure and lasted for up to 6 weeks ( 29 ). Demyelination occurring in the corpus callosum and cerebral cortex affect the functions of the iso-cortex, which regulates the motor function resulting in motor impairment ( 30 31 ).…”

Apamin Enhances Neurite Outgrowth and Regeneration after Laceration Injury in Cortical Neurons

“…Although apamin is known to be a neurotoxic polypeptide, recent findings have reported that apamin potentially elicits important neuroprotective roles relevant to the treatment of CNS diseases [ 5 , 12 ]. Interestingly, pharmacological actions of apamin have been attributed to apoptosis, fibrosis, and various diseases [ 13 ].…”

Bee Venom: An Updating Review of Its Bioactive Molecules and Its Health Applications

“…Some of the most important neuronal diseases are PD, Alzheimer's disease (AD) and amyotrophic lateral sclerosis [57]. Some components of BV, such as PLA2 and apamin, have been studied as anti-neuroinflammation agents to improve the efficacy of some drugs against neurodegenerative disorders [40]. The relation between inflammation and neuronal diseases makes that previous section strongly related to the neuroprotective effects of BV.…”